Article ID Journal Published Year Pages File Type
8691621 World Neurosurgery 2018 17 Pages PDF
Abstract
With increased combined milrinone and catecholamine use for the treatment of cerebral vasospasm, physicians should be aware of the potential cardiac complications of these agents. Close monitoring with daily electrocardiograms may be helpful to detect changes that suggest cardiotoxicity. If changes are noted, an echocardiogram and cardiology consultation may be warranted.
Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , ,